Registration Options

Activity Dates: 04/19/2021 - 04/19/2024

Members can access this product for only $35. Log in or Join now!

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Traumatic brain injury (TBI) is a leading cause of morbidity and mortality with increasing incidence worldwide. Falls, motor vehicle crashes, and intentional self-harm are primary causes of TBI, which may lead to long-term complications or death. The focus of this presentation is the persistent and long-term neurologic sequelae of TBI, including post-traumatic epilepsy, post-traumatic headache, post-traumatic endocrinopathies and post-concussive syndrome. Pharmacological treatments are often indicated for these chronic sequelae of TBI. However, the evidence base for pharmacologic treatments in specific post-traumatic disorders is sparse and there is often variance in the literature regarding efficacy of given agents; this is likely due to a variety of factors including heterogeneity in injury type, injury severity, and criteria for defining post-traumatic sequalae. Furthermore, polypharmacy is prevalent in these patients due to the presence of multiple comorbid neurologic and psychiatric conditions post-TBI which are often difficult-to-treat; the literature is also sparse regarding implications of polypharmacy in this population, though there is increasing recognition of the effects of excess anticholinergic burden on worsening cognition in this at-risks population. Nevertheless, the pharmacist can play a strong role in the management of TBI given the large number of pharmacological interventions needed in this population.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course. (sign in first)
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (sign in first)
  • Complete the evaluation at the end of the activity. (sign in first)
  • If necessary, complete the post-test retest no later than the closing activity date. (sign in first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (sign in first)

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Sunita Dergalust, PharmD, BCPS
Viet Nguyen, PharmD, MPH, MSc

View biographical information and disclosures

Learning Objectives

  1. Describe the clinical sequelae of traumatic brain injury.
  2. Develop a pharmacologic treatment plan for management of specific symptoms and comorbidities in traumatic brain injury patients.
  3. Identify medications that may worsen outcomes in the traumatic brain injury population.
  4. Discuss the considerations for managing medications and reducing polypharmacy in the polytrauma patient.

Continuing Education Credit and Disclosures

Activity Dates: 04/19/2021 - 04/19/2024
ACPE Contact Hours: 1.25
ACPE Number: 0284-0000-21-020-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.